LILLY FDA Approval ANDA 060003

ANDA 060003

LILLY

FDA Drug Application

Application #060003

Application Sponsors

ANDA 060003LILLY

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001TABLET;ORALEQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**0V-CILLIN KPENICILLIN V POTASSIUM
002TABLET;ORALEQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**0V-CILLIN KPENICILLIN V POTASSIUM
003TABLET;ORALEQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**0V-CILLIN KPENICILLIN V POTASSIUM

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 60003
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.